Next Article in Journal
Therapeutic Drug Monitoring of Infliximab and Adalimumab through Concentration and Anti-Drug Antibodies Assessment; Comparison of Sanquin Diagnostics and Theradiag Assays
Previous Article in Journal
Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab
Previous Article in Special Issue
Allogeneic HLA Humoral Immunogenicity and the Prediction of Donor-Specific HLA Antibody Development
 
 
Article

Article Versions Notes

Antibodies 2024, 13(3), 72; https://doi.org/10.3390/antib13030072
Action Date Notes Link
article pdf uploaded. 2 September 2024 16:01 CEST Version of Record https://www.mdpi.com/2073-4468/13/3/72/pdf-vor
article supplementary file uploaded. 2 September 2024 16:01 CEST - https://www.mdpi.com/2073-4468/13/3/72#supplementary
article xml file uploaded 3 September 2024 12:20 CEST Original file -
article xml uploaded. 3 September 2024 12:20 CEST Update -
article pdf uploaded. 3 September 2024 12:21 CEST Updated version of record https://www.mdpi.com/2073-4468/13/3/72/pdf-vor
article html file updated 3 September 2024 12:24 CEST Original file -
article xml file uploaded 4 September 2024 07:48 CEST Update -
article xml uploaded. 4 September 2024 07:48 CEST Update -
article pdf uploaded. 4 September 2024 07:48 CEST Updated version of record https://www.mdpi.com/2073-4468/13/3/72/pdf-vor
article html file updated 4 September 2024 07:50 CEST Update -
article xml file uploaded 5 September 2024 07:31 CEST Update -
article xml uploaded. 5 September 2024 07:31 CEST Update https://www.mdpi.com/2073-4468/13/3/72/xml
article pdf uploaded. 5 September 2024 07:31 CEST Updated version of record https://www.mdpi.com/2073-4468/13/3/72/pdf
article html file updated 5 September 2024 07:33 CEST Update https://www.mdpi.com/2073-4468/13/3/72/html
Back to TopTop